CASC Cascadian Therapeutics, Inc. (delisted)

10.02

0.00 (0.00%)

Pre Market

Last Updated: 01:00:00

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Cascadian Therapeutics, Inc. (delisted)	NASDAQ:CASC	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	10.02	7.15	9.97				0	01:00:00

Oncothyreon to Present at Cowen and Company 34th Annual Health Care Conference

26/02/2014 1:00pm

PR Newswire (US)

Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Cascadian Therapeutics, Inc. Charts.

SEATTLE, WA, Feb. 26, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Cowen and Company 34^th Annual Health Care Conference in Boston on Wednesday, March 5, 2014 at 9:20 a.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.